Kerendia Unione Europea - lituano - EMA (European Medicines Agency)

kerendia

bayer ag - finerenone - renal insufficiency, chronic; diabetes mellitus, type 2 - renino ir angiotenzino sistemos veikiantys vaistai - kerendia is indicated for the treatment of chronic kidney disease (stage 3 and 4 with albuminuria) associated with type 2 diabetes in adults.

Dimethyl fumarate Mylan Unione Europea - lituano - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dimetilfumaratas - išsėtinė sklerozė, grįžtamoji-pervedimo - imunosupresantai - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma Unione Europea - lituano - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetilfumaratas - išsėtinė sklerozė, grįžtamoji-pervedimo - imunosupresantai - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Kimmtrak Unione Europea - lituano - EMA (European Medicines Agency)

kimmtrak

immunocore ireland limited - tebentafusp - uveal neoplasms - antinavikiniai vaistai - kimmtrak is indicated as monotherapy for the treatment of human leukocyte antigen (hla)-a*02:01-positive adult patients with unresectable or metastatic uveal melanoma.

Dimethyl fumarate Teva Unione Europea - lituano - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - dimetilfumaratas - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresantai - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Accord Unione Europea - lituano - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dimetilfumaratas - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresantai - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Piperacillin/Tazobactam Kalceks Lituania - lituano - SMCA (Valstybinė vaistų kontrolės tarnyba)

piperacillin/tazobactam kalceks

as kalceks - piperacilinas/tazobaktamas - milteliai infuziniam tirpalui - 2000 mg/250 mg - piperacillin and beta-lactamase inhibitor

Piperacillin/Tazobactam Kalceks Lituania - lituano - SMCA (Valstybinė vaistų kontrolės tarnyba)

piperacillin/tazobactam kalceks

as kalceks - piperacilinas/tazobaktamas - milteliai infuziniam tirpalui - 4000 mg/500 mg - piperacillin and beta-lactamase inhibitor

Dimethyl fumarate STADA Lituania - lituano - SMCA (Valstybinė vaistų kontrolės tarnyba)

dimethyl fumarate stada

stada arzneimittel ag - dimetilfumaratas - skrandyje neirios kietosios kapsulės - 120 mg - dimethyl fumarate

Dimethyl fumarate STADA Lituania - lituano - SMCA (Valstybinė vaistų kontrolės tarnyba)

dimethyl fumarate stada

stada arzneimittel ag - dimetilfumaratas - skrandyje neirios kietosios kapsulės - 240 mg - dimethyl fumarate